WES for WT and SCID mT3-2D KPC Tumors and mT3-2D cell line

To determine the influence of in vivo tumor growth and antitumor immune responses on the generation of tumor neoepitopes, we performed whole exome sequencing (WES) on the mT3-2D cell line, WT tumors and SCID tumors DNA was extracted from the whole tumor tissue of the 5 WT mT3-2D subcutaneous tumors, the 5 SCID mT3-2D subcutaneous tumors and the mT3-2D cell line, and then WES was performed